Asia-Pacific Journal of Clinical Oncology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

---
Asia-Pacific Journal of Clinical Oncology, Ahead of Print. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - November 10, 2017 Category: Cancer & Oncology Source Type: research

CBX3/heterochromatin protein 1 gamma is significantly upregulated in patients with non –small cell lung cancer
ConclusionWe report a significant upregulation of CBX3/HP1‐gamma in NSCLC patients, and also a possible relationship between CBX3/HP1‐gamma expression and EGFR mutation. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - November 10, 2017 Category: Cancer & Oncology Authors: Shih ‐Chieh Chang, Yi‐Chun Lai, Yen‐Chung Chen, Nai‐Kuan Wang, Wei‐Shu Wang, Jiun‐I Lai Tags: ORIGINAL ARTICLE Source Type: research

Molecular targets for the therapy of cancer associated with metabolic syndrome (transcription and growth factors)
Asia-Pacific Journal of Clinical Oncology, EarlyView. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - November 8, 2017 Category: Cancer & Oncology Source Type: research

MicroRNA profiles in neuroblastoma: Differences in risk and histology groups
Asia-Pacific Journal of Clinical Oncology, EarlyView. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - November 8, 2017 Category: Cancer & Oncology Source Type: research

Comparison between site and central radiological assessments for patients with recurrent glioblastoma on a clinical trial
Asia-Pacific Journal of Clinical Oncology, EarlyView. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - November 8, 2017 Category: Cancer & Oncology Source Type: research

Pathological outcomes in rectal cancer following laparoscopic surgery
Asia-Pacific Journal of Clinical Oncology,Volume 14, Issue 2, Page e175-e180, April 2018. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - November 8, 2017 Category: Cancer & Oncology Source Type: research

---
Asia-Pacific Journal of Clinical Oncology, Ahead of Print. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - November 8, 2017 Category: Cancer & Oncology Source Type: research

---
Asia-Pacific Journal of Clinical Oncology,Volume 14, Issue 2, Page e175-e180, April 2018. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - November 8, 2017 Category: Cancer & Oncology Source Type: research

Molecular targets for the therapy of cancer associated with metabolic syndrome (transcription and growth factors)
Abstract Metabolic syndrome (MS) is one of the leading risk factors for the development of cardiovascular diseases, type II diabetes mellitus and reproductive system diseases. Currently, not only cardiovascular disease and reproductive history risks related with MS are frequently discussed, but it has been also shown that MS is associated with increased risk of some common cancers (endometrial cancer, postmenopausal breast cancer, colorectal cancer, biliary tract cancers and liver cancer for men). Further studies are required to understand the mechanisms of the involvement of MS components in the pathogenesis of malignant ...
Source: Asia-Pacific Journal of Clinical Oncology - November 8, 2017 Category: Cancer & Oncology Authors: Natalia V. Yunusova, Irina V. Kondakova, Larisa A. Kolomiets, Sergey G. Afanas'ev, Alena L. Chernyshova, Igor V. Kudryavtsev, Anastasia A. Tsydenova Tags: REVIEW Source Type: research

Comparison between site and central radiological assessments for patients with recurrent glioblastoma on a clinical trial
ConclusionWhile the difference between site and central PFS dates was statistically significant, the 0.3‐month median difference is small. The variability within central review is consistent with previous studies, highlighting the challenges in MRI interpretation in this context. A small proportion of patients benefited from treatment well beyond the centrally determined progression date, reinforcing that clinical status together with radiology results are important determinants of whether a therapy is effective for an individual. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - November 8, 2017 Category: Cancer & Oncology Authors: Kathryn M. Field, Greg Fitt, Mark A. Rosenthal, John Simes, Anna K. Nowak, Elizabeth H. Barnes, Kate Sawkins, Christine Goh, Bradford A. Moffat, Simon Salinas, Lawrence Cher, Helen Wheeler, Elizabeth J. Hovey, Pramit M. Phal, Tags: ORIGINAL ARTICLE Source Type: research

MicroRNA profiles in neuroblastoma: Differences in risk and histology groups
ConclusionIn this study, we represent microRNA expression profiles of neuroblastoma patients’ tissue with different clinical, histological grade, differentiation, and treatment status, and which could be informative for new therapies targeting microRNAs. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - November 8, 2017 Category: Cancer & Oncology Authors: Kemal Ergin, Safiye Akta ş, Zekiye Altun, Gülden Dınız, Nur Olgun Tags: ORIGINAL ARTICLE Source Type: research

Attitudes of patients with metastatic cancer towards research biopsies
Asia-Pacific Journal of Clinical Oncology, EarlyView. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - November 6, 2017 Category: Cancer & Oncology Source Type: research